2003 Scientific Articles

2003 Immunization Safety Branch Publications

2003 Peer-Reviewed Journal Articles

1. Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, et al. The risk of anaphylaxis following vaccination of children and adolescents. Pediatrics 2003;112:815-20.
2. Chen RT, Lane JM. Myocarditis: the unexpected return of smallpox vaccine adverse events. Lancet. 2003 Oct 25;362(9393):1345-6.
3. Chen RT. Introduction (Guest Editor: Vaccine Safety Issues). Semin Pediatr Infect Dis. 2003 Jul;14(3):187.
4. DeStefano F, VerstraetenT, Jackson LA, et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. ArchofNeurol 2003;60:504-9.
5. DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev of Vaccines 2003;2(1):21-29.
6. Gust, DA, Woodruff, R, Kennedy, A, Brown, C, Sheedy, K Hibbs, B. Parental Perceptions Surrounding Risks and Benefits of Immunizations. Semin Pediatr Infect Dis. 2003 Jul;14(3):207-12.
7. Haber P, DeStefano F. Influenza vaccination and Guillain Barré syndrome. Clin Immunol. 2003; 109(3):359; author reply 360-1.
   http://www.ncbi.nlm.nih.gov/pubmed/14697752
8. Hutwagner L, Thompson WW, Seeman GM, Treadwell T. The Bioterrorism Preparedness and Response Early Aberration Reporting System (EARS). Journal of Urban Health 2003 ;Supplement 1:i89-i96.
9. Jackson LA, Neuzil KM, Onchee Y, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, and Thompson WW. Effectiveness of pneumococcalpolysaccharide vaccine in older adults. NEJM 2003;348:1747-55.
10. Jacobson SH, Sewell EC, Allwine DA, Medina EA, Weniger BG. Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms.  Expert Review of Vaccines 2003;2(1):15-19.
11. Kelly WN. The quality of published adverse drug event reports. Ann Pharmacotherapy. 2003:37(12):1774-1778.
12. Kohl K, Bonhoeffer J, Chen R,Duclos P,Heijbel H,Heininger U,Loupi E and The Brighton Collaboration.  The Brighton Collaboration: Enhancing comparability of vaccine safety data. Pharmacoepidemiol Drug Safety 2003;12:335–40.
13. Lloyd JC, Haber P,Mootrey GT, Braun MM,  Chen RT, and VAERS Working Group Adverse event reporting rates followingtetanus-diphtheria and tetanus toxoid vaccinations: Data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine. 2003 Sep 8;21(25-26):3746-50.
14. Mell L, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM,Chen RT. Polio Extra-Immunization in Children Less Than Two Years Old Following Changes in Immunization Recommendations. Pediatrics 2003;111:296–301.
15. Naleway AL, Belongia EA, Greenlee, RT, Kieke BA, Chen RT, Shay DK. Eczematous Skin Disease and Recall ofPast Diagnoses: Implications for Smallpox Vaccination.  Ann Int Med 2003 Jul 1;139(1):1-7.
16. Tierney BC, Martin SW, Franzke LH, Marano N, Reissman DB, Louchart RD, Goff JA, Rosenstein NE, Sever JL, and McNeil MM. Serious Adverse Events among Participants in the Centers for Disease Control and Prevention’s Anthrax Vaccine and Antimicrobial Availability Program for Persons at Risk for Bioterrorism-Related Inhalational Anthrax. Clin Infect Dis 2003;37:905-911.
17. Thompson WW, Shay D, Weintraub E, Brammer L, Cox N, Anderson L, Fukuda K. Deaths in the United States attributable to influenza and respiratory syncytial virus, 1990-1999. JAMA 2003;289:179-186.
18. Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003;112:1039-48.
19. Verstraeten T, DeStefano F, Chen RT, Miller E. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Expert Review Vaccines 2003;2:89-97.
20. Verstraeten T, Jumaan AO,  Mullooly JP, Seward JF, Izurieta HS, DeStefano F, Black SB, Chen RT.A Retrospective Cohort Study of the Association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics 2003;112:e98–103.
21. Verstraeten T, DeStefano F, Chen RT and Miller E. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Expert Review Vaccines 2003;2(1):21-29.
22. Yih WK, Lieu TA, Rêgo VH, O'Brien MA, Shay DK, Yokoe DS, Platt R. Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination. BioMedCentral Public Health 2003, 3:20.

2003 CDC Publications

1. CDC. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001. 2003;52:(SS-1):1-24
2. CDC. Smallpox vaccination and adverse reactions: Guidance for clinicians. MMWR 2003;52(No. RR-4):1-28.
3. CDC. Update: Multistate Outbreak of Monkeypox- Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR 2003;52:642-646.
4. Cono J, Casey CG, Bell D. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR 2003;52(No. RR-4):1-28
5. Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ. Recommendations for using smallpox vaccine in a pre-event vaccination program; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003;52(No. RR-7):1-16